147 related articles for article (PubMed ID: 2436961)
1. Functional nature of glomerular injury in progressive diabetic glomerulopathy.
Tomlanovich S; Deen WM; Jones HW; Schwartz HC; Myers BD
Diabetes; 1987 May; 36(5):556-65. PubMed ID: 2436961
[TBL] [Abstract][Full Text] [Related]
2. Nature of the glomerular capillary injury in human membranous glomerulopathy.
Shemesh O; Ross JC; Deen WM; Grant GW; Myers BD
J Clin Invest; 1986 Mar; 77(3):868-77. PubMed ID: 2419362
[TBL] [Abstract][Full Text] [Related]
3. Charge selectivity of proteinuria in diabetic glomerulopathy.
Nakamura Y; Myers BD
Diabetes; 1988 Sep; 37(9):1202-11. PubMed ID: 3410164
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier.
Friedman S; Jones HW; Golbetz HV; Lee JA; Little HL; Myers BD
Diabetes; 1983 May; 32 Suppl 2():40-6. PubMed ID: 6086024
[TBL] [Abstract][Full Text] [Related]
5. Glomerular function in advanced human diabetic nephropathy.
Winetz JA; Golbetz HV; Spencer RJ; Lee JA; Myers BD
Kidney Int; 1982 May; 21(5):750-6. PubMed ID: 6180214
[TBL] [Abstract][Full Text] [Related]
6. Effects of exercise on glomerular passage of macromolecules in patients with diabetic nephropathy and in healthy subjects.
Ala-Houhala I
Scand J Clin Lab Invest; 1990 Feb; 50(1):27-33. PubMed ID: 1690442
[TBL] [Abstract][Full Text] [Related]
7. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.
Carrie BJ; Myers BD
Kidney Int; 1980 May; 17(5):669-76. PubMed ID: 6157049
[TBL] [Abstract][Full Text] [Related]
8. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.
Morelli E; Loon N; Meyer T; Peters W; Myers BD
Diabetes; 1990 Jan; 39(1):76-82. PubMed ID: 1698674
[TBL] [Abstract][Full Text] [Related]
9. Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
Plum J; Bünten B; Németh R; Grabensee B
J Am Soc Nephrol; 1998 Dec; 9(12):2223-34. PubMed ID: 9848776
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans.
Golbetz H; Black V; Shemesh O; Myers BD
Am J Physiol; 1989 Jan; 256(1 Pt 2):F44-51. PubMed ID: 2463770
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of proteinuria in diabetic glomerular disease.
Myers BD
J Hypertens Suppl; 1990 Mar; 8(1):S41-6. PubMed ID: 2332816
[TBL] [Abstract][Full Text] [Related]
12. Progression of overt nephropathy in non-insulin-dependent diabetes.
Myers BD; Nelson RG; Tan M; Beck GJ; Bennett PH; Knowler WC; Blouch K; Mitch WE
Kidney Int; 1995 Jun; 47(6):1781-9. PubMed ID: 7543961
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function.
Myers BD; Winetz JA; Chui F; Michaels AS
Kidney Int; 1982 Apr; 21(4):633-41. PubMed ID: 6178872
[TBL] [Abstract][Full Text] [Related]
14. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
Ruggenenti P; Mosconi L; Sangalli F; Casiraghi F; Gambara V; Remuzzi G; Remuzzi A
Kidney Int; 1999 Mar; 55(3):984-94. PubMed ID: 10027935
[TBL] [Abstract][Full Text] [Related]
15. Glomerular capillary wall function in human lupus nephritis.
Friedman S; Strober S; Field EH; Silverman E; Myers BD
Am J Physiol; 1984 May; 246(5 Pt 2):F580-91. PubMed ID: 6720964
[TBL] [Abstract][Full Text] [Related]
16. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus.
Zietse R; Derkx FH; Weimar W; Schalekamp MA
J Am Soc Nephrol; 1995 Jun; 5(12):2057-66. PubMed ID: 7579054
[TBL] [Abstract][Full Text] [Related]
17. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease.
Scandling JD; Myers BD
Kidney Int; 1992 Apr; 41(4):840-6. PubMed ID: 1381005
[TBL] [Abstract][Full Text] [Related]
18. Glomerular response to hyperglycemia in human diabetic nephropathy.
Remuzzi A; Viberti G; Ruggenenti P; Battaglia C; Pagni R; Remuzzi G
Am J Physiol; 1990 Oct; 259(4 Pt 2):F545-52. PubMed ID: 2221091
[TBL] [Abstract][Full Text] [Related]
19. Converting enzyme inhibition and glomerular size selectivity in diabetic nephropathy.
Meyer TW; Morelli E; Loon N; Peters W; Myers BD
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S64-8. PubMed ID: 16989068
[TBL] [Abstract][Full Text] [Related]
20. Effect of colloid volume expansion on glomerular barrier size-selectivity in humans.
Shemesh O; Deen WM; Brenner BM; McNeely E; Myers BD
Kidney Int; 1986 Apr; 29(4):916-23. PubMed ID: 3712975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
